First-line Chemotherapy for Extensive-disease Small Cell Lung Cancer: A Network Meta-analysis
First-line Chemotherapy for Extensive-disease Small Cell Lung Cancer: A Network Meta-analysis
About this item
Full title
Author / Creator
Publisher
China: Chinese Anti-Cancer Association Chinese Antituberculosis Association
Journal title
Language
Chinese
Formats
Publication information
Publisher
China: Chinese Anti-Cancer Association Chinese Antituberculosis Association
Subjects
More information
Scope and Contents
Contents
Regimens that combine irinotecan or etoposide with cisplatin or carboplatin have been recommended as first-line regimen for extensive-disease small cell lung cancer (ED-SCLC). In our network meta-analysis, we synthesized the direct and indirect lines of evidence to rank the short-term efficacies of these recommended chemotherapy regimens.
We sea...
Alternative Titles
Full title
First-line Chemotherapy for Extensive-disease Small Cell Lung Cancer: A Network Meta-analysis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_45285d8f85db4b47aefce5ee61efc00d
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_45285d8f85db4b47aefce5ee61efc00d
Other Identifiers
ISSN
1009-3419
E-ISSN
1999-6187
DOI
10.3779/j.issn.1009-3419.2016.04.02
